Abstract
Patients with multivalvular disease (MVD) are common and often present with heterogeneous valve defects. Evaluation is complicated by interactions among various valve pathologies. Trials and guidelines focus primarily on single-valve disease, providing few recommendations for the treatment of patients with MVD. This article provides an insight into percutaneous treatment possibilities for this heterogeneous patient population.
| Original language | English |
|---|---|
| Pages (from-to) | 142-146 |
| Number of pages | 5 |
| Journal | Interventional Cardiology: Reviews, Research, Resources |
| Volume | 14 |
| Issue number | 3 |
| DOIs | |
| State | Published - 1 Dec 2019 |
Keywords
- Intervention
- Multivalvular disease
- Transcatheter aortic valve implantation
- Transcatheter mitral valve repair
Fingerprint
Dive into the research topics of 'Multivalvular disease: Percutaneous management in 2019 and beyond'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver